24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Equashield
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:55
Can Israel survive a nuclear strike?
10:18
Yad2 now valued at $420 million as investors line up for potential sale
09:43
Israel’s AI dilemma: Strategy or blind alignment?
13:43
Full list of Israeli high-tech layoffs in 2025
More stories
Buzz
Most popular
Daily
Weekly
1
Insight Partners hit by cyber attack with possible data leaks
2
CyberArk’s surge, Wiz and Cato prepare for IPOs: Israeli cyber firms ready for the next big move
3
How Intel ruined an Israeli startup it bought for $2B—and lost the AI race
4
Riskified cuts staff as struggles continue
5
Techtonic to invest over $140 million to build one of Israel's largest data centers
More news
Equashield
1 stories about Equashield
Biotech company Equashield sells 25% stake to Nordic Capital at $1.3 billion valuation
06.10.22
|
Golan Hazani
CEO and co-founder Eric Shem-Tov is the largest shareholder at the company, which has registered sales in the hundreds of millions of dollars to hospitals across the world for its manual and automated solutions for the compounding and administration of hazardous drugs
